Morning Brew Daily Ozempic the Anti-Addiction Drug, Age of Streaming Mergers, & Bezos's Boat
May 23, 2023
The podcast dives into the buzz surrounding Ozempic, revealing its potential not just for weight loss but also as an anti-addiction treatment. As streaming platforms merge, the future of entertainment is questioned. The discussion also highlights a critical water conservation agreement amidst a historic drought in the West. Lastly, it humorously critiques public reactions to Jeff Bezos's grand yacht proposal, spotlighting the intersection of wealth and perception. Tune in for a blend of serious issues and lighthearted commentary!
AI Snips
Chapters
Transcript
Episode notes
Toby Gets Recognized
- Toby Howell was recognized by a listener from Jamaica while at brunch.
- This highlighted the global reach of the Morning Brew podcast.
Ozempic's Anti-Addiction Potential
- Ozempic, originally a diabetes drug, is showing potential as an anti-addiction treatment.
- Anecdotal evidence suggests it suppresses cravings for various substances and habits.
Max: The New Streaming Giant
- HBO Max rebranded as "Max," combining content from HBO and Discovery.
- This reflects a broader trend of streaming service consolidation to compete with Netflix.